世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
トピックス別レポート一覧 生化学的薬物の市場調査レポート
- 医薬
-
- 生化学的薬物
- このリストは、生化学的薬物に関するレポートを新刊順に紹介しています。例えば、代謝性薬物、組織細胞機能薬、外力障害薬に関する調査レポート (技術動向、市場規模予測)を紹介しています。
- 濾胞性リンパ腫 (腫瘍学) - 開発段階の治療薬 2021年
- Follicular Lymphoma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Follicular Lymphoma (Oncology) - Drugs in Development, 2021SummaryFollicular Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Follicular Lymphoma pipeline landscape.The report provides comprehensive information on the therapeut…
- このレポートの詳細ページはこちら
- 扁平上皮非小細胞肺がん (腫瘍学) - 開発段階の治療薬 2021年
- Squamous Non-Small Cell Lung Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Squamous Non-Small Cell Lung Cancer (Oncology) - Drugs in Development, 2021SummarySquamous Non-Small Cell Lung Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Squamous Non-Small Cell Lung Cancer pipeline landscape.The report pro…
- このレポートの詳細ページはこちら
- 未分化大細胞リンパ腫（ALCL) (腫瘍学) - 開発段階の治療薬 2021年
- Anaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Anaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021SummaryAnaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021 provides an overview of the Anaplastic Large Cell Lymphoma (ALCL) pipeline landscape.The repo…
- このレポートの詳細ページはこちら
- 未分化甲状腺がん (腫瘍学) - 開発段階の治療薬 2021年
- Anaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Anaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021SummaryAnaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Anaplastic Thyroid Cancer pipeline landscape.The report provides comprehensive informatio…
- このレポートの詳細ページはこちら
- 末梢性T細胞性リンパ腫 (PTCL) (腫瘍学) - 開発段階の治療薬 2021年
- Peripheral T-Cell Lymphomas (PTCL) (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Peripheral T-Cell Lymphomas (PTCL) (Oncology) - Drugs in Development, 2021SummaryPeripheral T-Cell Lymphomas (PTCL) (Oncology) - Drugs in Development, 2021 provides an overview of the Peripheral T-Cell Lymphomas (PTCL) pipeline landscape.The report provid…
- このレポートの詳細ページはこちら
- 傍神経節腫 (頸動脈小体腫瘍) (腫瘍学) - 開発段階の治療薬 2021年
- Paraganglioma (Glomus Jugulare Tumor) (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Paraganglioma (Glomus Jugulare Tumor) (Oncology) - Drugs in Development, 2021SummaryParaganglioma (Glomus Jugulare Tumor) (Oncology) - Drugs in Development, 2021 provides an overview of the Paraganglioma (Glomus Jugulare Tumor) pipeline landscape.The repo…
- このレポートの詳細ページはこちら
- 皮膚T細胞性リンパ腫 (腫瘍学) - 開発段階の治療薬 2021年
- Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021SummaryCutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Cutaneous T-Cell Lymphoma pipeline landscape.The report provides comprehensive informatio…
- このレポートの詳細ページはこちら
- 脳腫瘍 (腫瘍学) - 開発段階の治療薬 2021年
- Brain Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Brain Cancer (Oncology) - Drugs in Development, 2021SummaryBrain Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Brain Cancer pipeline landscape.The report provides comprehensive information on the therapeutics under development…
- このレポートの詳細ページはこちら
- 難治性慢性リンパ球性白血病 (CLL) (腫瘍学) - 開発段階の治療薬 2021年
- Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021SummaryRefractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) pip…
- このレポートの詳細ページはこちら
- 転移性膵臓腺がん (腫瘍学) - 開発段階の治療薬 2021年
- Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021SummaryMetastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Adenocarcinoma of The Pancreas pipeline landsc…
- このレポートの詳細ページはこちら
- 転移性膵がん (腫瘍学) - 開発段階の治療薬 2021年
- Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021SummaryMetastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Pancreatic Cancer pipeline landscape.The report provides comprehensive i…
- このレポートの詳細ページはこちら
- 転移性卵巣がん (腫瘍学) - 開発段階の治療薬 2021年
- Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021SummaryMetastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Ovarian Cancer pipeline landscape.The report provides comprehensive informatio…
- このレポートの詳細ページはこちら
- 転移性前立腺がん (腫瘍学) - 開発段階の治療薬 2021年
- Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021SummaryMetastatic Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Prostate Cancer pipeline landscape.The report provides comprehensive informa…
- このレポートの詳細ページはこちら
- 転移性腎細胞がん (腫瘍学) - 開発段階の治療薬 2021年
- Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021SummaryMetastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Renal Cell Carcinoma pipeline landscape.The report provides compre…
- このレポートの詳細ページはこちら
- 転移性黒色腫 (腫瘍学) - 開発段階の治療薬 2021年
- Metastatic Melanoma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Metastatic Melanoma (Oncology) - Drugs in Development, 2021SummaryMetastatic Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Melanoma pipeline landscape.The report provides comprehensive information on the therapeut…
- このレポートの詳細ページはこちら
- 中枢神経系 (CNS) がん (腫瘍学) - 開発段階の治療薬 2021年
- Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021SummaryCentral Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Central Nervous System (CNS) Cancer pipeline landscape.The report pro…
- このレポートの詳細ページはこちら
- 唾液腺がん (腫瘍学) - 開発段階の治療薬 2021年
- Salivary Gland Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Salivary Gland Cancer (Oncology) - Drugs in Development, 2021SummarySalivary Gland Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Salivary Gland Cancer pipeline landscape.The report provides comprehensive information on the the…
- このレポートの詳細ページはこちら
- 成長ホルモン欠乏 (欠損) 症 (代謝障害) - 開発段階の治療薬 2021年
- Growth Hormone Deficiency (Metabolic Disorders) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Growth Hormone Deficiency (Metabolic Disorders) - Drugs in Development, 2021SummaryGrowth Hormone Deficiency (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Growth Hormone Deficiency pipeline landscape.The report provides co…
- このレポートの詳細ページはこちら
- 髄膜腫 (腫瘍学) - 開発段階の治療薬 2021年
- Meningioma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Meningioma (Oncology) - Drugs in Development, 2021SummaryMeningioma (Oncology) - Drugs in Development, 2021 provides an overview of the Meningioma pipeline landscape.The report provides comprehensive information on the therapeutics under development for M…
- このレポートの詳細ページはこちら
- 腎細胞がん (腫瘍学) - 開発段階の治療薬 2021年
- Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ｜ 英文レポート
- Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021SummaryRenal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Renal Cell Carcinoma pipeline landscape.The report provides comprehensive information on the therap…
- このレポートの詳細ページはこちら
他産業の新着レポートを見る
カテゴリ別にレポートを見る
